Tiny Mineral, Massive Market Opportunity

Imagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's food supply. Right now, an under-the-radar company just debuted on the New York Stock Exchange with an IPO and it's currently priced under $15...

Get the full name of this company by clicking here.

John Sakys Biography and Net Worth

CFO of Mesa Laboratories

John V. Sakys joined us in October 2012 as our Chief Financial Officer. From 2009 through October 2012, Mr. Sakys held several positions with The Berry Company, LLC, and its predecessor company, Local Insight Regatta Holdings, Inc., most recently as its Vice President and Chief Accounting Officer. From 2001 to 2009, Mr. Sakys was the Vice President and Chief Financial Officer of Isonics Corporation, a NASDAQ listed company based in the Denver area. From September 2000 to April 2001, Mr. Sakys was the Controller of AuraServ Communications. From July 1998 to September 2000, Mr. Sakys was Director of Financial Reporting for Media One, Inc. From December 1994 to July 1998, Mr. Sakys was an audit manager at Ernst and Young LLP. Mr. Sakys received his Bachelor’s degree in Business Economics with an emphasis in accounting from the University of California at Santa Barbara and is a Certified Public Accountant.

What is John Sakys' net worth?: The estimated net worth of John Sakys is at least $1.31 million as of March 22nd, 2023. Mr. Sakys owns 9,696 shares of Mesa Laboratories stock worth more than $1,312,838 as of December 24th. This net worth approximation does not reflect any other assets that Mr. Sakys may own. Additionally, Mr. Sakys receives an annual salary of $582,290.00 as CFO at Mesa Laboratories. Learn More about John Sakys' net worth.
How old is John Sakys?: Mr. Sakys is currently 55 years old. There are 2 older executives and no younger executives at Mesa Laboratories. The oldest executive at Mesa Laboratories is Mr. Gary M. Owens, CEO, President & Director, who is 56 years old. Learn More on John Sakys' age.
What is John Sakys' salary?: As the CFO of Mesa Laboratories, Inc., Mr. Sakys earns $582,290.00 per year. The highest earning executive at Mesa Laboratories is Mr. Gary M. Owens, CEO, President & Director, who commands a salary of $1,100,000.00 per year. Learn More on John Sakys' salary.
How do I contact John Sakys?: The corporate mailing address for Mr. Sakys and other Mesa Laboratories executives is 12100 W 6TH AVE, LAKEWOOD CO, 80228. Mesa Laboratories can also be reached via phone at (303) 987-8000 and via email at [email protected]. Learn More on John Sakys' contact information.
Has John Sakys been buying or selling shares of Mesa Laboratories?: John Sakys has not been actively trading shares of Mesa Laboratories over the course of the past ninety days. Most recently, John Sakys sold 2,128 shares of the business's stock in a transaction on Friday, March 24th. The shares were sold at an average price of $167.01, for a transaction totalling $355,397.28. Following the completion of the sale, the chief financial officer now directly owns 9,696 shares of the company's stock, valued at $1,619,328.96. Learn More on John Sakys' trading history.
Who are Mesa Laboratories' active insiders?: Mesa Laboratories' insider roster includes Brian Archbold (SVP), Gregory DiNoia (SVP), Evan Guillemin (Director), David Kelly (Director), Gary Owens (CEO), John Sakys (CFO), John Schmieder (Director), and John Sullivan (Director). Learn More on Mesa Laboratories' active insiders.
Are insiders buying or selling shares of Mesa Laboratories?: During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,017 shares worth more than $473,470.16. The most recent insider tranaction occured on October, 28th when CEO Gary M Owens sold 2,518 shares worth more than $286,095.16. Insiders at Mesa Laboratories own 4.4% of the company. Learn More about insider trades at Mesa Laboratories.
Information on this page was last updated on 10/28/2024.

John Sakys Insider Trading History at Mesa Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/24/2023	Sell	2,128	$167.01	$355,397.28	9,696
3/22/2023	Sell	2,500	$171.62	$429,050.00	9,696
3/15/2023	Sell	1,000	$165.71	$165,710.00	9,696
3/9/2023	Sell	400	$169.97	$67,988.00	9,696
2/9/2023	Sell	1,000	$184.27	$184,270.00	9,696
1/23/2023	Sell	2,100	$210.19	$441,399.00	9,696
6/21/2022	Sell	722	$188.22	$135,894.84	8,678
4/20/2022	Sell	72	$250.44	$18,031.68	7,514
3/23/2022	Sell	930	$251.29	$233,699.70
12/10/2021	Sell	1,758	$324.74	$570,892.92
11/11/2021	Sell	1,000	$317.12	$317,120.00
10/20/2021	Sell	2,000	$309.86	$619,720.00
9/10/2021	Sell	1,400	$270.21	$378,294.00	8,914
8/12/2021	Sell	1,000	$275.16	$275,160.00	8,514
7/12/2021	Sell	1,000	$278.77	$278,770.00	8,514
7/12/2021	Sell	1,000	$278.77	$278,770.00
6/16/2021	Sell	2,119	$255.67	$541,764.73	9,633
3/12/2021	Sell	2,500	$263.84	$659,600.00	4,850
1/6/2021	Sell	16	$290.00	$4,640.00	3,366
11/17/2020	Sell	984	$290.00	$285,360.00	4,334
10/8/2020	Sell	942	$276.90	$260,839.80	4,292
9/1/2020	Sell	298	$250.00	$74,500.00	3,698
8/14/2020	Sell	1,000	$244.00	$244,000.00	4,500
8/15/2018	Sell	1,000	$203.50	$203,500.00	3,500
11/17/2016	Sell	1,000	$127.14	$127,140.00	2,000

John Sakys Buying and Selling Activity at Mesa Laboratories

Mesa Laboratories Company Overview

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Today's Range

Now: $135.40

$131.16

$136.58

50 Day Range

MA: $120.61

$98.59

$135.91

2 Week Range

Now: $135.40

$83.68

$141.17

Volume

53,744 shs

Average Volume

41,695 shs

Market Capitalization

$735.36 million

P/E Ratio

N/A

Dividend Yield

0.48%

Beta

0.86

Tiny Mineral, Massive Market Opportunity

From i2i Marketing Group, LLC | Ad

Get the full name of this company by clicking here.

John Sakys Biography and Net Worth

What is John Sakys' net worth?

How old is John Sakys?

What is John Sakys' salary?

How do I contact John Sakys?

Has John Sakys been buying or selling shares of Mesa Laboratories?

Who are Mesa Laboratories' active insiders?

Are insiders buying or selling shares of Mesa Laboratories?